[Hospital epidemiology of ST-segment elevation myocardial infarction and feasibility of primary percutaneous coronary intervention in an interhospital network: data from a multicenter, prospective and observational study VENERE (VENEto acute myocardial infarction REgistry].

Zoran Olivari, Francesco Di Pede, Elena Schievano, Stefano Brocco, Angelo Ramondo, Luigi La Vecchia, Totò Giujusa, Guerrino Zuin, Riccardo Neri, Giampaolo Pasquetto, Antonio Iavernaro, Leone Rossi, Federico Corbara
{"title":"[Hospital epidemiology of ST-segment elevation myocardial infarction and feasibility of primary percutaneous coronary intervention in an interhospital network: data from a multicenter, prospective and observational study VENERE (VENEto acute myocardial infarction REgistry].","authors":"Zoran Olivari,&nbsp;Francesco Di Pede,&nbsp;Elena Schievano,&nbsp;Stefano Brocco,&nbsp;Angelo Ramondo,&nbsp;Luigi La Vecchia,&nbsp;Totò Giujusa,&nbsp;Guerrino Zuin,&nbsp;Riccardo Neri,&nbsp;Giampaolo Pasquetto,&nbsp;Antonio Iavernaro,&nbsp;Leone Rossi,&nbsp;Federico Corbara","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Primary percutaneous coronary intervention (pPCI) is the most effective reperfusion treatment of acute ST-segment elevation myocardial infarction (STEMI), but logistic- and organization-related problems affect its feasibility. The aim of this study was to investigate a) the requirements of reperfusion therapies, and b) the feasibility of pPCI as suggested by the current guidelines, in the Veneto Region.</p><p><strong>Methods: </strong>With the aim to treat with pPCI most of the patients with high-risk STEMI regardless of the type of admitting hospital, a single treatment protocol was developed and shared by the majority of Cardiology Departments in the Veneto Region. Data of all consecutive patients with STEMI were prospectively recorded and subsequently and independently compared with administrative data.</p><p><strong>Results: </strong>In 28 participating hospitals, 1160 consecutive patients with STEMI were enrolled during a 6-month period: in 999 symptom onset was < 12 hours. Based on the registry data, it is possible to estimate that 697 patients/million of inhabitants/year are admitted in Cardiology Departments with the initial diagnosis of STEMI: 86% are admitted < 12 hours from symptom onset and 58% of them have at least one characteristic of high risk. The strategy of immediate coronary angiography and possible PCI was carried out in 52.3% of eligible patients: in 55.8 and 47.5% of high- and low-risk STEMI and from 17.1 to 75.1% based on the type of admitting hospital. Recanalization with pPCI was obtained < 90 min from the diagnosis in 70 and 32% of patients treated on site and transferred, respectively.</p><p><strong>Conclusions: </strong>The absolute number of patients with STEMI eligible for reperfusion therapies is lower than previously reported. The reperfusion strategy based on pPCI was much more related to the type of admitting hospital than to the clinical characteristics of the patients. pPCI performed as suggested by the current guidelines is feasible in patients admitted in hospitals with interventional facilities available 24 hours/day, but in those who need to be transferred it is necessary to modify the existing pathways and/or treatment protocols.</p>","PeriodicalId":80289,"journal":{"name":"Italian heart journal : official journal of the Italian Federation of Cardiology","volume":"6 Suppl 6 ","pages":"57S-64S"},"PeriodicalIF":0.0000,"publicationDate":"2005-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Italian heart journal : official journal of the Italian Federation of Cardiology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Primary percutaneous coronary intervention (pPCI) is the most effective reperfusion treatment of acute ST-segment elevation myocardial infarction (STEMI), but logistic- and organization-related problems affect its feasibility. The aim of this study was to investigate a) the requirements of reperfusion therapies, and b) the feasibility of pPCI as suggested by the current guidelines, in the Veneto Region.

Methods: With the aim to treat with pPCI most of the patients with high-risk STEMI regardless of the type of admitting hospital, a single treatment protocol was developed and shared by the majority of Cardiology Departments in the Veneto Region. Data of all consecutive patients with STEMI were prospectively recorded and subsequently and independently compared with administrative data.

Results: In 28 participating hospitals, 1160 consecutive patients with STEMI were enrolled during a 6-month period: in 999 symptom onset was < 12 hours. Based on the registry data, it is possible to estimate that 697 patients/million of inhabitants/year are admitted in Cardiology Departments with the initial diagnosis of STEMI: 86% are admitted < 12 hours from symptom onset and 58% of them have at least one characteristic of high risk. The strategy of immediate coronary angiography and possible PCI was carried out in 52.3% of eligible patients: in 55.8 and 47.5% of high- and low-risk STEMI and from 17.1 to 75.1% based on the type of admitting hospital. Recanalization with pPCI was obtained < 90 min from the diagnosis in 70 and 32% of patients treated on site and transferred, respectively.

Conclusions: The absolute number of patients with STEMI eligible for reperfusion therapies is lower than previously reported. The reperfusion strategy based on pPCI was much more related to the type of admitting hospital than to the clinical characteristics of the patients. pPCI performed as suggested by the current guidelines is feasible in patients admitted in hospitals with interventional facilities available 24 hours/day, but in those who need to be transferred it is necessary to modify the existing pathways and/or treatment protocols.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
st段抬高型心肌梗死的医院流行病学和医院间网络中初级经皮冠状动脉介入治疗的可行性:来自多中心、前瞻性和观察性研究VENERE (VENEto急性心肌梗死登记)的数据。
背景:原发性经皮冠状动脉介入治疗(pPCI)是急性st段抬高型心肌梗死(STEMI)最有效的再灌注治疗方法,但其可行性受到后勤和组织问题的影响。本研究的目的是调查a)再灌注治疗的要求,b)目前指南建议的pPCI在威尼托地区的可行性。方法:针对大多数高危STEMI患者,无论入院类型如何,均采用pPCI治疗,制定了单一的治疗方案,并由威尼托地区大多数心内科共享。前瞻性记录所有连续STEMI患者的数据,并随后与管理数据进行独立比较。结果:在28家参与研究的医院中,在6个月内纳入了1160例STEMI患者,其中999例症状发作时间< 12小时。根据登记数据,可以估计每年有697名患者/百万居民因STEMI的初始诊断而入住心内科:86%的患者在症状出现后12小时内入院,其中58%的患者至少具有一项高风险特征。在符合条件的患者中,有52.3%的患者采取了立即冠状动脉造影和可能的PCI治疗策略,其中高危STEMI患者为55.8%,低危STEMI患者为47.5%,根据入院医院类型,这一比例从17.1%到75.1%不等。在现场治疗和转移治疗的患者中,分别有70%和32%的患者在诊断后< 90分钟使用pPCI进行再通。结论:符合再灌注治疗条件的STEMI患者的绝对数量低于先前报道。基于pPCI的再灌注策略与入院医院类型的关系大于与患者临床特征的关系。按照现行指南的建议实施pPCI对于在有介入设施的医院住院的患者是可行的,但对于那些需要转院的患者,有必要修改现有的途径和/或治疗方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Evidence for a "gender paradox" in diabetic patients undergoing percutaneous coronary intervention: adverse preprocedural risk but favorable long-term clinical outcome in women. Ectasia of the ascending aorta at the time of aortic valve surgery: replace or relax? A clinical approach for cardiovascular monitoring of HIV-infected patients. Results from an observational cohort study. Surgical treatment of an aneurysm originating from a Kommerell's diverticulum in the right-sided aortic arch with retroesophageal component. Double aneurysm of the left ventricular wall following cardiac perforation after aortic valvuloplasty.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1